Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The JAK2 V617F mutation in patients with cerebral venous thrombosis.

Journal of thrombosis and haemostasis : JTH - 1 Jun 2012

Passamonti S M, Biguzzi E, Cazzola M, Franchi F, Gianniello F, Bucciarelli P, Pietra D, Mannucci P M, Martinelli I

Abstract excerpt

BACKGROUND: It is currently unclear whether or not cerebral venous thrombosis, such as splanchnic venous thrombosis, can be the first manifestation of an underlying myeloproliferative neoplasm. OBJECTIVE: To determine the prevalence of the JAK2 V617F mutation in patients with a first episode of cerebral venous thrombosis. PATIENTS: In this retrospective cohort study, patients with cerebral venous thrombosis were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Intracranial Thrombosis

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Venous Thrombosis

Source

Identifiers

PMID: 22469236
DOI: 10.1111/j.1538-7836.2012.04719.x

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The JAK2 V617F mutation in patients with cerebral venous thrombosis.PMID 22469236Read ↗

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?Semantic proximity Read ↗

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?Semantic proximity Read ↗

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.Semantic proximity Read ↗

Cerebral venous sinus thrombosis associated with JAK2 V617F mutation-related pre-primary myelofibrosis: a case report and literature review.Semantic proximity Read ↗

Cerebral Venous Sinus Thrombosis as the First Manifestation of JAK2V617F-positive Essential Thrombocythemia.Semantic proximity Read ↗

Frequency and characteristics of the JAK2 V617F mutation in 23 cerebral venous sinus thrombosis patients with thrombocytosis.Semantic proximity Read ↗

Is the JAK2 V617F mutation a hallmark for different forms of thrombosis?Semantic proximity Read ↗

Cerebral vein thrombosis.Semantic proximity Read ↗

Characteristics of patients with cerebral sinus venous thrombosis and JAK2 V617F mutation.Semantic proximity Read ↗

JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases.Semantic proximity Read ↗

Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: Current status and future perspectives.Semantic proximity Read ↗

Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.